Medication info
Rozetel Tablet 40/10/10 mg

Rozetel Tablet 40/10/10 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tabletEzetimibe›10mg / 1 tablet
Manufacturer / importer
Green Cross Corporation
Appearance
Pink oval film-coated tablet
Packaging
30 tablets/box [6 tablets/PTP X 5]
Approval status
Active

MFDS item code 202106691 · Approved 2021.09.29 · Insurance code 643606260

Summary

Main use
Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This drug is for use only in adults. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of telmisartan orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, measure blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly, switching to this drug (a combination tablet containing the same amounts of each active ingredient) may be considered for convenience.

Ingredients

Manufacturer
Green Cross Corporation

Efficacy & effects

Treatment of essential hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of end-organ damage
  • high-risk diabetes
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
View approved original text

This medication is used for patients who need to take Telmisartan and Rosuvastatin/Ezetimibe simultaneously. Telmisartan is effective for treating essential hypertension and helps reduce the risk of myocardial infarction, stroke, and death due to cardiovascular diseases in high-risk patients who cannot use ACE inhibitors. Rosuvastatin/Ezetimibe improves cholesterol and triglyceride levels in patients with hypercholesterolemia and dyslipidemia and is used to increase HDL-cholesterol levels. By using these two medications together, it effectively controls blood pressure and blood lipid levels to improve cardiovascular health.

How to take

Adult dose

This drug is for use only in adults. The dose should be individualized for each patient based on the efficacy and tolerability of telmisartan and the rosuvastatin/ezetimibe combination. Take 1 tablet once daily with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). ○ Telmisartan 1. Essential hypertension Adults: The recommended dose is 40 mg of telmisartan orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Telmisartan produces an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose is 80 mg of telmisartan orally once daily. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting telmisartan to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. • Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin/ezetimibe The rosuvastatin/ezetimibe combination is administered once daily, with or without food. Patients should continue a standard cholesterol-lowering diet before and during treatment with the rosuvastatin/ezetimibe combination. The dose of the rosuvastatin/ezetimibe combination should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dose range of the rosuvastatin/ezetimibe combination is 5/10mg∼20/10mg once daily. The recommended initial dose is 5/10mg once daily. The dose may be adjusted for patients requiring a greater reduction in LDL cholesterol. After starting the rosuvastatin/ezetimibe combination or adjusting the dose, measure blood lipid levels at intervals of at least 4 weeks and adjust the dose accordingly; the dose may be increased to a maximum of 20/10mg once daily. For patients taking telmisartan and the rosuvastatin/ezetimibe combination concomitantly, switching to this drug (a combination tablet containing the same amounts of each active ingredient) may be considered for convenience.

Precautions

This medication can cause serious harm to the fetus and newborn, so if pregnancy is confirmed, it should be discontinued immediately. Serious muscle-related side effects may occur rarely, so if severe muscle pain or weakness symptoms appear, consult a doctor immediately. Patients with liver dysfunction or a history of liver diseases should avoid taking this medication, and regular liver function tests are important. Patients with severe renal impairment or those taking specific medications should avoid or be cautious with this medication. This medication may cause allergic reactions, so patients with hypersensitivity to the active ingredient or components should not take it. Used to treat hypertension or hyperlipidemia, it helps control blood pressure and cholesterol levels. While taking this medication, regular check-ups for blood pressure, serum potassium, liver and kidney function, and muscle condition should be conducted to identify any abnormalities. Excessive alcohol intake or a history of liver disease requires caution when taking this medication. Dizziness may occur while taking this medication, so caution is advised when driving or operating dangerous machinery. There may be drug interactions, so if taking other medications, it is essential to inform healthcare professionals. Particular caution is required when combined with antihypertensives, anticoagulants, certain antibiotics, and other lipid-lowering agents. Common side effects during this medication include headache, dizziness, dyspepsia, muscle pain, and elevated liver function levels. If severe allergic reactions, liver damage, myopathy, or angioedema occur, discontinue use immediately and seek medical attention. Regular blood tests and health checks as directed by a doctor are essential while taking this medication.

Side effects

Increased ALT, increased AST, increased Ɣ-GTP, increased ALP, abdominal pain, oral ulcers, vomiting, chest pain, palpitations, dizziness, shortness of breath, dysfunction of the Eustachian tube, tympanic membrane perforation, acute kidney injury, hematuria, shingles, pneumonia, non-small cell lung cancer, hair loss, dysuria, rhinitis, discomfort in the oropharynx, lung disease, unspecified gastrointestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, ear ringing, hearing loss, halitosis, fatty liver, chest tightness, facial edema, strange sensations, drug intolerance, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, orthostatic dizziness, migraine, diabetes, impaired glucose tolerance, depression, bronchitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatic toxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased alkaline phosphatase, irregular heart rate, osteoarthritis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cysts, eyelid droop, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, abdominal pain, diarrhea, dyspepsia, abdominal distention, abdominal discomfort, dry mouth, abnormal liver function, liver disorders, increased sweating, itching, rash, erythema, vascular edema, drug rashes, toxic skin rashes, eczema, urticaria, myalgia, lumbago, muscle cramps, arthralgia, pain in limbs, tendon pain, acute renal failure, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, elevated serum creatine kinase, decreased hemoglobin, shock, loss of consciousness, interstitial pneumonia, rhabdomyolysis, palpitations, fatigue, nausea, inadequate response, headache, facial spasms, sensory abnormalities, paralysis, cough, hyperventilation, flushing, erectile dysfunction, weakness, edema, decreased libido, facial swelling, conjunctivitis, tinnitus, petechiae, polyneuropathy, amnesia, peripheral neuropathy, diarrhea, Stevens-Johnson syndrome, drug reaction syndrome with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, edema, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, severe muscular weakness, oculobulbar weakness, elevated CK, constipation, pancreatitis, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival congestion, renal failure, abnormal liver function tests

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it must be stored in a sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This will help preserve the medication's efficacy for a long time.

Appearance and packaging

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/box [6 tablets/PTP X 5]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.